Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Price / Earnings (ltm)

Gilead Sciences Inc Price / Earnings (ltm) Chart (GILD)

Gilead Sciences Inc annual/quarterly Price / Earnings (ltm) from 2010 to 2020. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Gilead Sciences Inc Price / Earnings (ltm) for the quarter ending November 11, 2020 was 59.85 a -0.63% decrease of -0.38 year over year
  • Gilead Sciences Inc Price / Earnings (ltm) for the last 12 months ending November 11, 2020 was 59.85 a -0.63% decrease of -0.38 year over year
  • Gilead Sciences Inc Annual Price / Earnings (ltm) for 2020 was 59.85 a 0.60% increase of 0.36 from 2019
  • Gilead Sciences Inc Annual Price / Earnings (ltm) for 2020 was 59.49 a -0.37% decrease of -0.22 from 2019
  • Gilead Sciences Inc Annual Price / Earnings (ltm) for 2020 was 59.71 a -0.87% decrease of -0.52 from 2019
Other Valuation Metrics:
  • Gilead Sciences Inc Market Cap for the quarter ending June 06, 2018 was $92,110m a -14.87% decrease of -13,696m year over year
  • Gilead Sciences Inc Price / Book for the quarter ending June 06, 2018 was 4.47 a -4.33% decrease of -0.19 year over year
  • Gilead Sciences Inc Enterprise Value for the quarter ending June 06, 2018 was $96,545m a -14.87% decrease of -14,361m year over year
View Chart On Koyfin

Quarterly GILD Price / Earnings (ltm) Data

11/202059.85
11/202059.49
11/202059.71
11/202060.22
11/202060.49
11/202060.56
11/202060.68
11/202060.18
11/202059.58
11/202059.70

Annual GILD Price / Earnings (ltm) Data

202059.85
202059.49
202059.71
202060.22
202060.49
202060.56
202060.68
202060.18
202059.58
202059.70